Archives of Pediatric Infectious Diseases

Published by: Kowsar

Idiopathic Thrombocytopenic Purpura Is More Severe in Children with a Recent History of Vaccination

Akbar Shafiee 1 , Shiva Nazari 2 , * , Arsalan Hashemiaghdam 3 and Mohammad Taghi Sadeghi-Koupai 4
Authors Information
1 Tehran Heart Center, Tehran University of Medical Sciences, Tehran, IR Iran
2 Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
4 Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: October 01, 2013, 1 (3); 113-7
  • Published Online: October 29, 2013
  • Article Type: Research Article
  • Received: December 26, 2012
  • Revised: March 2, 2013
  • Accepted: April 16, 2013
  • DOI: 10.5812/pedinfect.9971

To Cite: Shafiee A, Nazari S, Hashemiaghdam A, Sadeghi-Koupai M T. Idiopathic Thrombocytopenic Purpura Is More Severe in Children with a Recent History of Vaccination, Arch Pediatr Infect Dis. 2013 ; 1(3):113-7. doi: 10.5812/pedinfect.9971.

Copyright © 2013, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Kliegman Robert. Nelson textbook of pediatrics. 2011;
  • 2. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med. 2005; 56: 425-42[DOI][PubMed]
  • 3. Rodeghiero F. Idiopathic thrombocytopenic purpura: an old disease revisited in the era of evidence-based medicine. Haematologica. 2003; 88(10): 1081-7[PubMed]
  • 4. Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child. 2000; 83(3): 220-2[PubMed]
  • 5. Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf. 2010; 33(1): 65-72[DOI][PubMed]
  • 6. Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Clin Pediatr (Phila). 2004; 43(8): 691-702[PubMed]
  • 7. Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthoj S. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity? Arch Dis Child. 2007; 92(8): 704-7[DOI][PubMed]
  • 8. Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010; 149(6): 855-64[DOI][PubMed]
  • 9. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346(13): 995-1008[DOI][PubMed]
  • 10. Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007; 21(4): 743-59[DOI][PubMed]
  • 11. Le Meignen M, Mossler P, Mates M, Mathey C, Hass A, Monpoux F, et al. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHemaP]. Arch Pediatr. 2008; 15(9): 1398-406[DOI][PubMed]
  • 12. O'Leary Sean T, Glanz Jason M, McClure David L, Akhtar Aysha, Daley Matthew F, Nakasato Cynthia, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012; 129(2): 248-255
  • 13. Kuhne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001; 358(9299): 2122-5[DOI][PubMed]
  • 14. Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008; 121(3)-12[DOI][PubMed]
  • 15. Blanchette VS, Carcao M. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost. 2003; 29(6): 605-17[DOI][PubMed]
  • 16. Buchanan GR. Thrombocytopenia during childhood: what the pediatrician needs to know. Pediatr Rev. 2005; 26(11): 401-9[PubMed]
  • 17. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005; 106(7): 2244-51[DOI][PubMed]
  • 18. Rajantie J, Zeller B, Treutiger I, Rosthoj S. Vaccination associated thrombocytopenic purpura in children. Vaccine. 2007; 25(10): 1838-40[DOI][PubMed]
  • 19. Wang JD, Huang FL, Chen PY, Wang TM, Chi CS, Chang TK. Acute immune thrombocytopenic purpura in infants: associated factors, clinical features, treatment and long-term outcome. Eur J Haematol. 2006; 77(4): 334-7[DOI][PubMed]
  • 20. O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012; 129(2): 248-55[DOI][PubMed]
  • 21. Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995; 345(8949): 567-9[PubMed]
  • 22. Wiersbitzky S, Bruns R, Muller C, Wiersbitzky H, Mentel R, Seidel W. Postvaccinal thrombocytopenia: fact or myth? Pediatr Hematol Oncol. 1995; 12(5): 503-5[PubMed]
  • 23. Cecinati Valerio, Principi Nicola, Brescia Letizia, Giordano Paola, Esposito Susanna. Vaccine administration and the development of immune thrombocytopenic purpura in children. Human vaccines & immunotherapeutics. 2013; 9(5)
  • 24. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of disease in childhood. 2001; 84(3): 227-229
  • 25. Mantadakis Elpis, Farmaki Evangelia, Buchanan George R. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management. The Journal of pediatrics. 2010; 156(4): 623-628
  • 26. Ronchi F, Cecchi P, Falcioni F, Marsciani A, Minak G, Muratori G, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Archives of disease in childhood. 1998; 78(3): 273-274
  • 27. Hsieh Yuh-Lin, Lin Lung-Huang. Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades. Journal of the Chinese Medical Association. 2010; 73(12): 634-637
  • 28. Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol. 2007; 14(5): 515-9[DOI][PubMed]
  • 29. Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009; 145(2): 235-44[DOI][PubMed]
  • 30. Rehman A. Immune thrombocytopenia in children with reference to low-income countries. East Mediterr Health J. 2009; 15(3): 729-37[PubMed]
  • 31. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88(1): 3-40[PubMed]
  • 32. Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, et al. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. Pediatr Blood Cancer. 2009; 52(2): 259-62[DOI][PubMed]
  • 33. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med. 1966; 275(7): 352-6[DOI][PubMed]
  • 34. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J. 1996; 15(1): 88-90[PubMed]
  • 35. Sauve LJ, Bettinger J, Scheifele D, Halperin S, Vaudry W, Law B. Postvaccination thrombocytopenia in Canada. Pediatr Infect Dis J. 2010; 29(6): 559-61[DOI][PubMed]
  • 36. Stowe J, Kafatos G, Andrews N, Miller E. Idiopathic thrombocytopenic purpura and the second dose of MMR. Arch Dis Child. 2008; 93(2): 182-3[DOI][PubMed]
Readers' Comments